At the core of MABS is the use of magnetically controlled systems that enhance surgical site exposure without necessitating additional trocars or incisions. The traditional laparoscopic approach, though minimally invasive, can be limited by restricted instrument maneuverability and inadequate visualization, especially in morbidly obese individuals where excessive fatty tissue creates formidable barriers within the abdominal cavity. By employing externally controlled magnets, surgeons can manipulate surgical instruments and retractors internally with unprecedented dexterity, improving access to critical anatomical structures while maintaining the minimally invasive nature of the procedure.

One of the most profound benefits of MABS lies in its potential to address hepatomegaly, the pathological enlargement of the liver commonly observed in obese patients. Enlarged fatty livers can obscure the operative field, complicating essential steps such as gastric sleeve formation or Roux-en-Y gastric bypass construction. The magnetic devices facilitate dynamic retraction of the liver and surrounding tissues, enabling clear visualization and safer dissection. This improved operative view translates directly to increased precision, reduced operative time, and minimized risk of inadvertent injury to adjacent organs or vasculature.

Further amplifying the advantages of magnet-assisted techniques, these flexible magnetic instruments allow a more ergonomic approach for surgeons. Traditional laparoscopic tools are constrained by fixed entry ports, limiting the angles and range of motion. Magnetically maneuvered instruments overcome these physical constraints by providing a controllable magnetic field that permits three-dimensional orientation within the abdominal cavity. Surgeons can thus pivot instruments smoothly according to situational needs, maintaining optimal exposure while reducing fatigue and enhancing procedural efficiency.

The conceptual foundation of MABS draws on previous successes in using magnet technology in general and thoracic surgery. This cross-disciplinary adaptation into bariatrics underscores an important trend in surgical innovation: the repurposing of existing tools to tackle specific challenges posed by complex pathologies. Employing magnetic assistance in bariatric procedures aligns with a broader commitment to refine surgical precision amid increasing rates of obesity worldwide and the concomitant surge in demand for effective surgical treatments.

Importantly, MABS demonstrates a favorable safety profile. Early systematic reviews reveal that the magnetic apparatus does not induce adverse tissue reactions or magnetic interference with electronic medical devices, alleviating concerns about biocompatibility and patient safety. The magnets utilized are carefully calibrated to generate sufficient force for tissue retraction while preventing trauma, ensuring that the internal manipulation remains gentle yet effective. This balance is crucial for maintaining tissue integrity and promoting optimal postoperative recovery.

Another dimension of magnet-assisted surgery is the potential reduction of incisional complications. Because magnetic retraction minimizes the need for additional incisions, patients benefit from fewer scarring and lower wound infection risks. This aspect contributes to accelerated recovery times, decreased postoperative pain, and superior cosmetic outcomes, which collectively enhance patient satisfaction. Given the psychosocial aspects tied to obesity surgery, such qualitative improvements in the surgical experience are especially meaningful.

Technological advancements continue to push the boundaries of MABS, with ongoing research directed toward refining magnet design and integrating robotic assistance. Future iterations may feature programmable magnetic arrays capable of automated repositioning, coordinated through advanced imaging guidance systems. Such developments would propel MABS not only into a realm of enhanced manual control but also toward the forefront of smart, semi-autonomous surgical platforms tailored for complex bariatric interventions.

While the promise of MABS is compelling, experts acknowledge that widespread adoption necessitates rigorous clinical validation. Large-scale, multicenter trials are critical to establish standardized protocols, delineate long-term outcomes, and compare efficacy directly against conventional laparoscopic techniques. Comprehensive cost-benefit analyses will further guide healthcare systems in investing in this technology, ensuring equitable access for patients who stand to gain the most from improved surgical modalities.

Moreover, MABS embodies a paradigm shift toward multidisciplinary collaboration. Engineers, surgeons, and material scientists must coalesce efforts to optimize device functionality, usability, and safety. This convergence fosters innovation ecosystems where clinical needs drive technological solutions, accelerating the translation from experimental setups to routine clinical practice. The bariatric community stands to gain substantially from such synergistic endeavors.

Patient-centric care remains paramount in MABS. Enhanced visualization and precision wrought by magnetic assistance facilitate personalized surgical strategies tailored to individual anatomical variations and disease severity. This adaptability ensures that bariatric surgery is no longer a one-size-fits-all intervention but a customizable therapeutic avenue that maximizes benefits while mitigating risks for each patient’s unique clinical context.

In summary, magnet-assisted bariatric surgery is a transformative innovation that addresses critical limitations of current minimally invasive weight-loss surgeries. By utilizing magnetic fields to improve exposure and instrument maneuverability within the challenging anatomical milieu of obese patients, MABS promises to deliver safer, more effective, and patient-friendly surgical care. As clinical evidence accumulates and technology advances, this technique has the potential to become a new standard in the treatment of obesity, ultimately improving outcomes and quality of life for millions afflicted by this global health epidemic.

Subject of Research: Magnet-assisted bariatric surgery (MABS) as an advanced minimally invasive surgical technique for obesity treatment

Article Title: Current evidence and future perspectives on magnet-assisted bariatric surgery (MABS): a systematic review

Article References:
Chen, Y., Shiliang, D., Liu, Y. et al. Current evidence and future perspectives on magnet-assisted bariatric surgery (MABS): a systematic review. Int J Obes (2025). https://doi.org/10.1038/s41366-025-01966-4

Image Credits: AI Generated

DOI: 29 November 2025

Keywords: Magnet-assisted surgery, bariatric surgery, minimally invasive surgery, hepatomegaly, fatty liver disease, obesity treatment, surgical innovation, magnetic retraction, laparoscopic techniques

Obesity’s pathophysiology is multifactorial, involving complex interactions between genetic, environmental, and behavioral factors that culminate in excessive adiposity and metabolic dysregulation. Medical weight management strategies traditionally emphasize lifestyle modifications, dietary interventions, and pharmacotherapy, yet their long-term effectiveness is often hindered by patient adherence and physiological counter-regulatory mechanisms. The cohort study at hand meticulously compared outcomes between individuals undergoing bariatric surgery and those engaged in medically supervised weight loss programs, highlighting a pronounced divergence in health trajectories favoring surgical intervention.

Bariatric surgery encompasses a variety of procedures designed to induce substantial and sustained weight loss through anatomical and hormonal modifications. These surgical methods, such as Roux-en-Y gastric bypass and sleeve gastrectomy, not only reduce stomach capacity but also alter gut hormone profiles influencing satiety, glucose metabolism, and insulin sensitivity. The study’s findings underscore that beyond weight reduction alone, bariatric surgery exerts profound metabolic effects that significantly lower the incidence of obesity-related comorbidities compared to non-surgical management.

The investigators utilized robust longitudinal data, tracking metabolic outcomes over extended follow-up periods, to ascertain the durability of bariatric surgery’s protective benefits. They observed a marked reduction in new-onset diabetes, dyslipidemia, and hypertension among surgical patients, signaling enhanced metabolic health preservation. This suggests that bariatric surgery not only facilitates acute weight loss but also modifies disease progression pathways underlying metabolic syndromes.

It is crucial to note that the cohort design allowed for real-world assessments across diverse populations, reflecting pragmatic treatment scenarios. Such observational approaches, while limited in establishing causality, provide valuable insights into comparative effectiveness beyond the confines of randomized controlled trials. The study meticulously controlled for confounding variables, enhancing the reliability of its conclusions regarding the superiority of surgical intervention in risk mitigation.

The study’s technical rigor extends to its characterization of metabolic health markers, capturing changes in insulin resistance, inflammatory profiles, and lipid metabolism post-intervention. These metrics corroborate the notion that bariatric surgery exerts systemic benefits transcending mere weight loss, potentially recalibrating metabolic homeostasis to attenuate disease susceptibility.

Moreover, the findings have consequential implications for clinical guidelines and health policy. As obesity prevalence escalates globally, identifying interventions that yield sustained metabolic improvement is paramount. This research advocates for bariatric surgery as a frontline therapeutic option for eligible patients, potentially reshaping treatment algorithms and insurance coverage practices.

Nonetheless, the study acknowledges that bariatric surgery is not devoid of risks and warrants comprehensive multidisciplinary evaluation to optimize patient selection and postoperative care. Surgical complications, nutritional deficiencies, and psychological impacts necessitate vigilant management, underscoring the importance of expert teams in bariatric programs.

In light of these findings, future research avenues may explore mechanistic underpinnings of metabolic reprogramming post-surgery, aiming to emulate these effects via less invasive modalities. Additionally, long-term surveillance is essential to monitor durability of metabolic benefits and late-emerging sequelae.

The correspondingly significant reduction in metabolic comorbidities post-bariatric surgery amplifies the urgency for healthcare systems to increase accessibility and patient education regarding surgical options. Emphasizing informed decision-making and personalized treatment strategies will enhance outcomes for individuals grappling with obesity and its ripple effects.

In summation, this cohort study delivers robust evidence that bariatric surgery is a potent, durable strategy for preventing the onset of major metabolic diseases when contrasted with conventional medical weight management. Its findings herald a paradigm shift in tackling obesity-associated risks, underscoring surgery’s role not just in weight reduction but in comprehensive metabolic health restoration.

For clinicians, researchers, and policymakers alike, these insights consolidate the imperative to integrate bariatric surgery into holistic obesity management frameworks, leveraging its transformative potential to curb the global metabolic disease burden.

Subject of Research: Bariatric surgery versus medical weight management in reducing metabolic comorbidities in obesity

Article Title: [Not provided]

News Publication Date: [Not provided]

Web References: [Not provided]

References: doi:10.1001/jamanetworkopen.2025.30787

Image Credits: [Not provided]

Keywords: Weight loss, Surgery, Obesity, Body weight, Cohort studies, Metabolic health, Risk factors

Obesity is not merely about weight; it is a multifaceted issue that leads to various comorbidities. South Asian individuals, despite often being seen as fit and healthy, can have a higher risk of developing obesity-related health issues due to lifestyle factors and dietary patterns. The intricacies of these health risks often manifest differently than in other populations, highlighting the urgent need for targeted interventions. The new research promises a thoughtful exploration into these issues, aiming to bring effective solutions to the surface by engaging the community in meaningful ways.

The faith-based anti-obesity program targeted South Asian Americans, focused on the underlying cultural and religious elements that influence health behavior. Through this program, the researchers fostered an environment where participants could feel more connected and supported in their endeavors to lose weight and adopt healthier lifestyles. This aspect is crucial: when communities rally around a common cause, the potential for change exponentially increases. Using faith as a backbone for health initiatives allows for deeper engagement and commitment, leading to potentially lasting impact.

The study employed a prospective single-arm pre-post trial design, which is particularly effective for evaluating the changes in health metrics over time. This approach allowed the researchers to assess participants’ BMI, blood sugar levels, and blood pressure before and after the implementation of the program. The participants were actively involved in various activities ranging from dietary consultations to physical exercise, each session infused with cultural relevance to ensure higher retention and compliance. This strategy not only educated participants about healthy practices but also emphasized the importance of community and mutual support in achieving health goals.

One of the pivotal aspects of the study is its focus on cultural relevancy in health interventions. South Asian dietary customs and social structures play a critical role in shaping individuals’ health behaviors. Conventional obesity treatments often overlook these cultural nuances, which can lead to diminished effectiveness. By recognizing and incorporating culturally specific factors, the researchers could tailor the program to better suit the participants’ lifestyles, leading to remarkable improvements in their health outcomes.

The results of the trial were striking. Participants demonstrated significant reductions in BMI, with a notable percentage also reporting improved management of diabetes and hypertension. These findings underscore the potential of faith-oriented health initiatives as viable methods for combating obesity and related health conditions. The emphasis on spiritual engagement not only enriched the participants’ experiences but also reinforced their commitment to personal health improvement.

Community engagement proved crucial in the study’s execution, further highlighting a profound understanding of public health dynamics. Participants reported feeling more motivated and encouraged within a supportive group setting. This component was particularly essential in acknowledging that weight loss is not merely a physical endeavor but a journey that encompasses emotional and mental health aspects as well. With sustained support from their faith community, participants were more likely to stick to their health goals.

As obesity continues to challenge public health initiatives, this research opens doors for additional investigations into faith-based programs across diverse populations. The strong correlation between cultural identity and health behaviors suggests ample room for tailored interventions. These findings may set a precedent for future studies aimed at using community and faith-based frameworks to facilitate healthier lifestyle choices among various groups facing similar health challenges.

While this research focuses on South Asian Americans, its implications extend beyond this particular demographic. The integration of community-oriented, faith-based health initiatives presents a blueprint for addressing similar challenges in other minority populations. Although behaviors around food and exercise can be deeply entrenched and influenced by myriad factors, the success witnessed in this trial is clear evidence that a community-driven approach can yield meaningful change.

The impact of this study resonates on multiple levels: it contributes to the ever-evolving dialogue about obesity and chronic disease prevention, and it stimulates further academic inquiry into culture-centered health interventions. The methodology and findings of this trial could serve as a reference point for health policymakers, community leaders, and healthcare practitioners who aim to adapt existing frameworks to meet the needs of specific populations more effectively.

In conclusion, this faith-based anti-obesity program has played a pivotal role in addressing a critical health issue among South Asian Americans, showcasing the potential within community-driven approaches to foster substantial health improvements. The researchers have paved the way for additional studies that can continue to explore how faith and culturally nuanced strategies can influence health outcomes on a larger scale. Acknowledging and incorporating these elements into public health discussions can significantly enhance our understanding of obesity management and chronic disease prevention.

The implications of this research extend far beyond the immediate findings about BMI, diabetes, and hypertension. They underscore the power of community, culture, and faith in promoting health and wellness. A new horizon appears for future health interventions as we aim to bridge the gap between public health and personal responsibility through community empowerment.

Subject of Research: Faith-Based Anti-obesity Program Effects on BMI, Diabetes, and Hypertension in South Asian Americans

Article Title: Faith-Based Anti-obesity Program Effects on BMI, Diabetes, and Hypertension in South Asian Americans: A Prospective Single-Arm Pre-Post Trial

Article References:

Khosla, P., Doshi, R.H., Amin, K.S. et al. Faith-Based Anti-obesity Program Effects on BMI, Diabetes, and Hypertension in South Asian Americans: A Prospective Single-Arm Pre-Post Trial.
J GEN INTERN MED (2025). https://doi.org/10.1007/s11606-025-09767-1

Image Credits: AI Generated

DOI: 10.1007/s11606-025-09767-1

Keywords: Faith-based, obesity, South Asian Americans, health intervention, community support, BMI, diabetes, hypertension.

Historically, bariatric surgery, which includes procedures such as Roux-en-Y gastric bypass, sleeve gastrectomy, and adjustable gastric banding, has been hailed for its profound effects on weight reduction and metabolic health. However, a subset of patients experiences weight regain several months or years following surgery. This can be attributed to a complex interplay of physiological, behavioral, and psychological factors, including anatomical changes, hormonal adaptations, and lifestyle elements that challenge the durability of initial weight loss. Persistent weight gain not only diminishes the quality of life but also exposes patients to renewed risk of cardiovascular disease, type 2 diabetes, and other obesity-related complications.

The meta-analysis conducted by Golzarand and colleagues represents a pivotal effort to collate data from multiple randomized controlled trials and observational studies, aiming to assess the efficacy and safety of obesity medications in patients who have undergone bariatric surgery but exhibit inadequate weight control thereafter. Notably, the authors highlight that despite the widespread use of pharmacotherapy in the general obese population, post-bariatric pharmacologic management remains controversial and lacks a consensus-driven protocol. This ambiguity stems in part from the heterogeneity of studied drug classes, variations in surgical techniques, and diverse patient characteristics.

One of the key insights from this extensive review is the therapeutic potential of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in mitigating weight regain after surgery. These agents, originally developed for glycemic control in type 2 diabetes, have demonstrated marked anorectic effects, improved satiety, and enhanced energy expenditure. The meta-analysis underscores that administration of GLP-1 RAs postoperatively correlates with clinically meaningful reductions in body weight, a finding that may revolutionize postoperative obesity care by integrating pharmacologic adjuncts with surgical treatment.

In addition to GLP-1 receptor agonists, the comprehensive evaluation touches upon other pharmacological agents, including orlistat, phentermine-topiramate combination, and naltrexone-bupropion. Each of these drugs operates via distinct mechanisms: orlistat acts by inhibiting gastrointestinal lipases to reduce fat absorption; phentermine-topiramate influences central appetite regulation; and naltrexone-bupropion modulates reward pathways associated with eating behavior. The meta-analysis reveals variable but generally positive effects of these medications when used in the delicate postoperative phase, suggesting that personalized medication plans may be essential to optimize outcomes.

The research further delves into considerations surrounding timing, dosage, and duration of pharmacotherapy initiation after bariatric surgery. The lack of standardized guidelines has led to disparities in clinical practice, with some practitioners hesitant to prescribe obesity medications fearing adverse events or drug-surgery interactions. Golzarand et al. rigorously assess safety profiles, noting that the studied pharmacological agents exhibit acceptable tolerability, with side effects largely manageable and transient. Importantly, they emphasize a multidisciplinary approach involving surgeons, endocrinologists, dietitians, and mental health professionals to navigate the complexities of combined surgical and pharmacological obesity management.

Another salient point highlighted is the psychological dimension underpinning suboptimal postoperative weight loss. The meta-analysis calls attention to the role of pharmacotherapy in addressing not only physiological drivers of weight regain but also neurobehavioral and emotional factors that may compromise adherence to lifestyle modifications. In this context, medications affecting central nervous system pathways provide dual benefits: direct weight reduction and modulation of appetite-related cognitive processes.

The authors also discuss gaps in current research, advocating for more robust and large-scale clinical trials designed specifically to evaluate long-term outcomes of obesity medications post-bariatric surgery. Existing studies often suffer from heterogeneity in patient selection, follow-up duration, and outcome measures, limiting the extrapolation of findings to real-world clinical settings. Prospective, randomized trials with stratified patient cohorts are necessary to establish evidence-based protocols tailored to different surgical procedures and patient profiles.

In framing the meta-analysis as a practical guideline, Golzarand and colleagues propose an algorithmic approach for clinicians confronting postoperative weight regain. They recommend initiating pharmacotherapy when patients demonstrate significant weight regain — generally exceeding 10% of nadir weight — or when weight loss plateaus earlier than expected. This pragmatic framework underscores the importance of early intervention to prevent the re-emergence of obesity-related comorbidities and to sustain patient motivation by demonstrating continued support.

Crucially, the study also explores the cost-effectiveness implications of pharmacotherapy as an adjunct to bariatric surgery. While surgical procedures carry a substantial upfront cost, recurrent weight gain leads to increased healthcare utilization over time. By curtailing weight regain pharmacologically, the authors suggest potential downstream savings and enhanced long-term health economics, an argument likely to resonate with policymakers and insurance providers aiming to optimize resource allocation.

The meta-analysis does not ignore the pivotal role of patient education and sustained behavioral counseling. The authors advocate for integrating pharmacotherapy within a comprehensive obesity management program that prioritizes nutritional monitoring, physical activity encouragement, and psychological support. This holistic paradigm acknowledges that medication alone is insufficient unless embedded within a supportive care environment.

Broader implications of this research extend toward redefining post-bariatric clinical care standards globally. As obesity prevalence continues to rise and bariatric surgery remains a cornerstone treatment, standardized protocols to combat postoperative weight regain are urgently needed. The findings of this meta-analysis inspire optimism that combining surgical and pharmacological strategies can improve durability of weight loss, enhance patient quality of life, and reduce long-term health risks.

Moreover, the study opens avenues for future exploration of novel pharmacologic agents with enhanced efficacy and tailored safety profiles optimized for the postoperative context. Advances in precision medicine and an improved understanding of obesity pathophysiology at the molecular level may soon enable clinicians to individualize drug choice based on genetic, metabolic, and behavioral patient factors.

In conclusion, the meta-analysis by Golzarand, Toolabi, and Mirmiran represents a seminal contribution to obesity medicine, offering a nuanced synthesis of current evidence on the role of obesity medications following bariatric surgery. By bridging the gap between surgical success and long-term weight maintenance, this research provides an invaluable resource to clinicians seeking to confront the persistent challenge of postoperative weight regain. It heralds a new era in obesity treatment—one in which surgery and medication work synergistically to achieve sustainable health outcomes in this high-risk population.

Subject of Research:
Pharmacotherapy for managing recurrent weight gain and suboptimal clinical response in patients after bariatric surgery.

Article Title:
Obesity medications in patients with recurrent weight gain or suboptimal clinical response following bariatric surgery: a meta-analysis.

Article References:
Golzarand, M., Toolabi, K. & Mirmiran, P. Obesity medications in patients with recurrent weight gain or suboptimal clinical response following bariatric surgery: a meta-analysis.
Int J Obes (2025). https://doi.org/10.1038/s41366-025-01807-4

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41366-025-01807-4

The investigation into the long-term effects of pediatric obesity interventions comprises a robust cohort of over 6,700 individuals. Each participant had received treatment for obesity during their childhood, identified through the BORIS register, which is the Swedish Childhood Obesity Treatment Register. The researchers followed the subjects into young adulthood, utilizing an impressive array of national health databases, including the Swedish Patient Register, the Prescribed Drugs Register, and the Cause of Death Register. Furthermore, a control group from the general population, matched by age, sex, and residence, enriches the findings and allows for robust comparisons.

The obesity treatment program analyzed in this research focused on “behavioral lifestyle therapy.” This approach includes comprehensive support for children and their families to foster healthy dietary habits, increase physical activity, and improve sleep patterns. Despite the challenges associated with maintaining weight loss, the outcomes indicate that effective intervention during childhood can alleviate the burden of obesity-related diseases. Those who respond well to treatment show a significantly reduced risk for severe health problems such as type 2 diabetes, hypertension, and dyslipidemia as they transition into adulthood.

Despite these promising results regarding physical health, the study reveals a concerning aspect of mental health. Surprisingly, even among children who successfully lose weight through treatment, the risk of developing anxiety and depression in young adulthood remains unchanged. This finding challenges long-held beliefs that weight loss would positively influence mental health. Dr. Emilia Hagman, the lead researcher and an esteemed faculty member at the Department of Clinical Science, Intervention and Technology at Karolinska Institutet, articulates this disappointment, noting, “It has been believed that weight loss could decrease symptoms of depression and anxiety, but we can now show that it’s not the case.”

The implications of these findings highlight a critical need for parallel treatment strategies to address both the physical and psychological challenges faced by children with obesity. With mental health issues persisting despite physical health improvements, healthcare providers must consider integrated approaches to improve overall well-being. Dr. Hagman emphasizes the importance of early intervention, noting that timely treatment not only enhances physical health outcomes but also helps mitigate associated long-term risks.

In addition to traditional lifestyle therapy, recent advancements in pharmaceutical options warrant exploration. Although the study did not include GLP-1 analogues, a class of medications that have gained traction in the obesity treatment landscape, Dr. Hagman acknowledges their potential benefits. These medications, which help curb hunger, could offer a complementary avenue to traditional behavioral therapies, especially for children struggling to manage their appetite effectively. Nevertheless, she stresses that lifestyle intervention remains the cornerstone of treating childhood obesity.

The research sets the stage for future inquiries into more tailored therapies by identifying which interventions might be most beneficial for varying individuals. In an era where personalized medicine is becoming the gold standard, understanding the unique health markers that contribute to long-term success in obesity treatment is paramount. Future studies will undoubtedly build on this foundation to enhance therapeutic outcomes in both physical and mental health domains.

As childhood obesity continues to pose a significant public health challenge across the globe, the findings of this study offer a timely reminder of the complex interplay between physical health and mental well-being. While treating childhood obesity effectively can reduce immediate health risks, the persistent prevalence of anxiety and depression underscores the need for comprehensive approaches. By integrating physical health initiatives with mental health support, health practitioners can strive for a more holistic approach toward improving the lives of children with obesity.

Ultimately, this study serves to galvanize attention on critical mental health challenges that persist alongside physical treatment gains. The results reflect the pressing need for continuous research and advocacy in addressing not only the physical manifestations of childhood obesity but also the emotional scars that can linger as young individuals navigate their formative years and transition into adulthood. As the scientific community delves deeper into these findings, a renewed commitment to dual-focused treatment strategies offers hope for enhancing the overall quality of life for those affected by childhood obesity.

Given the concerning statistics and ongoing health ramifications, it is imperative that we mobilize resources, knowledge, and support for interventions targeting both weight management and mental health among children. The intersection of these two spheres will dictate not only the trajectory of individual lives but also the health landscape of future generations.

Subject of Research:
People

Article Title:
Effect of Pediatric Obesity Treatment on Long-Term Health

News Publication Date:
21-Jan-2025

Web References:
https://doi.org/10.1001/jamapediatrics.2024.5552

References:
(Information not provided in the original content)

Image Credits:
(Information not provided in the original content)

Keywords:
Childhood obesity, Depression, Anxiety, Type 2 diabetes, Hypertension, Public health, Pediatric obesity treatment, Behavioral lifestyle therapy